Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
718 |
|
| Actual shortage: | 20 (3%) | |
| Anticipated shortage: | 6 (1%) | |
| Avoided shortage: | 88 (12%) | |
| Resolved: | 604 (84%) | |
Discontinuation Reports |
235 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 235 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
89 (9%) |
|
Overdue reports |
19 (73%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-03-17 | 2021-05-19 | 135797 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2017-10-26 | 2018-08-23 | 27093 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2023-01-17 | 2023-02-02 | 181311 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2019-10-01 | 2020-01-13 | 95097 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-01-05 | 2021-01-21 | 130872 |
| LABETALOL HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2017-05-19 | 2019-03-09 | 10718 |
| LABETALOL HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2019-03-13 | 2024-12-10 | 78454 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2022-06-09 | 2022-07-12 | 162343 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2019-05-14 | 2019-08-31 | 84070 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-03-25 | 2020-04-29 | 109369 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2021-12-21 | 2022-01-04 | 151687 |
| MOVISSE | 0.35MG | TABLET | Avoided shortage | 2017-10-18 | 2018-02-09 | 26211 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-01-29 | 2020-02-26 | 104691 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2019-08-07 | 2020-01-23 | 91044 |
| MYL-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-01-06 | 2021-02-04 | 130906 |
| MYL-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2025-01-21 | 2025-03-03 | 248183 |
| MYL-PROPAFENONE | 150MG | TABLET | Resolved | 2017-09-22 | 2018-03-02 | 23160 |
| MYL-PROPAFENONE | 300MG | TABLET | Resolved | 2017-09-22 | 2018-03-02 | 23163 |
| MYL-SILDENAFIL | 100MG | TABLET | Avoided shortage | 2017-04-13 | 2017-07-17 | 6976 |
| MYL-SILDENAFIL | 50MG | TABLET | Resolved | 2017-04-04 | 2018-08-23 | 5307 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-ALPRAZOLAM | 2MG | TABLET | Discontinued | 2018-04-03 | 2018-08-01 | 44789 |
| MYLAN-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2017-11-23 | 2018-08-01 | 30380 |
| MYLAN-ALPRAZOLAM | 1MG | TABLET | Discontinued | 2017-08-24 | 2017-08-24 | 20234 |
| MYLAN-AMIODARONE | 200MG | TABLET | Discontinued | 2018-06-04 | 2018-08-01 | 51236 |
| MYLAN-AMOXICILLIN | Discontinued | 2019-10-03 | 2019-10-03 | 95280 | ||
| MYLAN-AMOXICILLIN | 250MG | CAPSULE | Discontinued | 2018-07-03 | 2018-07-04 | 53569 |
| MYLAN-ATENOLOL | 50MG | TABLET | Discontinued | 2018-06-04 | 2018-08-01 | 51248 |
| MYLAN-ATENOLOL | 25MG | TABLET | Discontinued | 2018-06-04 | 2018-06-08 | 51245 |
| MYLAN-ATENOLOL | 100MG | TABLET | Discontinued | 2018-06-04 | 2018-07-04 | 51258 |
| MYLAN-ATOMOXETINE | 40MG | CAPSULE | Discontinued | 2018-04-03 | 2018-08-01 | 44815 |
| MYLAN-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-04-03 | 2018-08-01 | 44821 |
| MYLAN-ATOMOXETINE | 25MG | CAPSULE | Discontinued | 2018-04-03 | 2018-08-01 | 44805 |
| MYLAN-ATOMOXETINE | 18MG | CAPSULE | Discontinued | 2018-04-03 | 2018-08-01 | 44799 |
| MYLAN-ATOMOXETINE | 80MG | CAPSULE | Discontinued | 2018-06-04 | 2018-07-04 | 51261 |
| MYLAN-ATOMOXETINE | 100MG | CAPSULE | Discontinued | 2018-06-04 | 2018-07-04 | 51264 |
| MYLAN-AZATHIOPRINE | 50MG | TABLET | Discontinued | 2017-07-18 | 2017-11-02 | 16099 |
| MYLAN-AZITHROMYCIN | 250MG | TABLET | Discontinued | 2017-11-23 | 2018-03-02 | 30362 |
| MYLAN-BISOPROLOL | 5MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 15811 |
| MYLAN-BISOPROLOL | 10MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 15816 |
| MYLAN-BOSENTAN | 62.5MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53603 |